 |
||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
DUBLIN, Ohio, July 7, 2004 — Cardinal Health, Inc. (NYSE: CAH), the leading provider of products and services supporting the health care industry, today announced its previously announced acquisition of ALARIS Medical Systems, Inc. has been completed and as a result ALARIS is now a wholly-owned subsidiary of Cardinal Health. ALARIS Medical Incorporated Masimo SET® Pulse Oximetry into its First Generation Modular Patient Care System SAN DIEGO, CA, March 31, 1999 — ALARIS Medical, Inc. (NASDAQ: ALRS) and Masimo Corporation today announced a licensing agreement under which ALARIS Medical plans to integrate Masimo Signal Extraction pulse oximetry technology into its first generation Modular Patient Care System. ALARIS Medical, through its wholly owned subsidiary, ALARIS Medical Systems, has been developing an innovative Patient Care System designed to enhance patient safety by reducing point-of-care medication errors through the integration of infusion therapy and patient monitoring. Adverse reactions to prescription drugs are the fourth leading cause of death nationally. With a significant market share of all U.S. hospital beds, ALARIS Medical is well positioned to reduce medication errors related to infusion therapy with the introduction of its Patient Care System. ALARIS Medical believes the use of Masimo SET pulse oximetry technology, with ALARIS Medical's Patient Care System, will help establish a new standard for patient safety. "As a global leader in the development of infusion therapy systems, we wanted state-of-the-art pulse oximetry technology for our first generation Patient Care System," said William J. Mercer, ALARIS Medical President & CEO. "Pulse oximeters are used in a variety of situations, but are of particular value for monitoring oxygenation and pulse rates during the delivery of certain anesthetic agents. In every application, accuracy and reliability are critical. Our due diligence, along with published clinical research, indicates that Masimo is rapidly becoming a technology leader in pulse oximetry. We're very impressed with this company and are pleased to partner with them in establishing a new standard of patient care," he added. "ALARIS Medical's Patient Care System is being designed to enhance patient safety by reducing point-of-care medication errors through the integration of infusion therapy and patient monitoring," said Robert S. White, ALARIS Medical Corporate Vice President of Business Development. " Masimo has created a novel approach to measure arterial oxygen saturation and pulse rate with significant clinical accuracy even in the presence of high levels of interfering signals or motion artifact. The integration of pulse oximetry into the ALARIS Medical Patient Care System demands the highest level of clinical accuracy. We felt Masimo was the only choice." "Over the past 30 years, ALARIS Medical's thermometers and infusion pumps have revolutionized and improved how patients are cared for today," said Joe E. Kiani, President and Chief Executive Officer of Masimo Corporation. "ALARIS Medical is once again redefining how infusion of therapeutics and pain relief should be delivered. This is not only an important relationship for the two companies, but I believe it is truly significant for patient care. We are delighted that we can, with Masimo SET pulse oximetry, assist ALARIS Medical in improving patient outcomes." Masimo Corporation is a privately held medical technology company that designs, develops and licenses advanced medical signal processing and sensor technology for the noninvasive monitoring of vital physiological parameters. Masimo has created a fundamentally unique method to measure arterial oxygen saturation and pulse rate. Masimo Signal Extraction pulse oximetry is the only technology clinically proven accurate during patient motion and is designed for accuracy during conditions of low perfusion, bright ambient light and electro-surgical interference. Masimo has licensed its Signal Extraction pulse oximetry OEM boards and proprietary single patient adhesive and reusable sensors to more than 25 international patient monitoring instrument providers including ALARIS Medical Systems. Masimo is located in Irvine, California. Cardinal Health Alaris® Products provide leading-edge solutions for the safe delivery of intravenous (IV) drugs. Specialized IV infusion systems, proprietary software applications, wireless solutions, needle-free consumables, monitoring devices, and bar-coding are part of a full range of products that help reduce medication errors. Cardinal Health assists health care professionals at the point of care in providing the safest possible medication delivery by:
|
||||
 |
 |
 |
 |